J&J’s Kenvue spinoff to hit IPO market this week in the biggest deal since late 2021

Johnson & Johnson’s consumer health company Kenvue is expected to hit the initial public offering market this week and mark the largest deal since late 2021.

Kenvue is parent to a host of household name brands, including Tylenol, Listerine, Band-Aid, Neutrogena and Nicorette.

“With over $2 billion in cash flow and a healthy 3.7% dividend,…